Skip to main content
Signal8

Bala Mohan

SEC insider (Form 3/4/5 filer). CIK 0001991787. SVP, Chief Development at Mersana Therapeutics, Inc. (MRSN). 25 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2026. Located in CAMBRIDGE, MA.

Companies Bala Mohan has filed insider reports for

  • Mersana Therapeutics, Inc. (MRSN): Officer, SVP, Chief Development
Bala Mohan profile photo

Bala Mohan

CIK: 0001991787

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (24.0%)

Position reduction

Option Exercises (M)5 (20.0%)

Derivative conversions

Awards (A)2 (8.0%)

Compensation grants

Other (G, F, J, C, D, …)12 (48.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mersana Therapeutics, Inc. logo
MRSN

Mersana Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (25 total)

  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    1.2K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    9.3K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    2.6K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    5.2K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    1.9K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    3.5K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Tender Offer
    Direct
    2.9K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    7.7K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    1.1K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Restricted Stock Units

    Direct
    700 shares-

1-10 of 25